Medical and Pharmaceutical Freenome gets FDA breakthrough designation for ‘SimpleScreen’ lung cancer blood test Achievement builds on firm securing agency's approval for a colorectal cancer test variation Rowan Dunne2 days ago
Medical and Pharmaceutical Manitoba Lung Association and BioMark use blood biopsy to tackle radon threat They are organising a feasibility study assessing the efficacy of BioMark's blood test on those exposed to the gas Rowan Dunne5 days ago
Medical and Pharmaceutical Lung cancer screening awareness remains low despite advances in early detection The 2026 Lung Health Barometer found only 33 per cent of adults knew low-dose CT screening is available for high-risk people Joseph MortonAugust 6, 2026
Medical and Pharmaceutical Median Technologies partners with Canon Medical to achieve lung cancer screening goals Their collaboration seeks to expedite deployment of Median's AI-powered nodule detection system Rowan DunneJuly 31, 2026
Medical and Pharmaceutical Stand Up To Cancer charity funds non-invasive lung cancer screening projects It will provide up to US$200K for each of the three initiatives Rowan DunneJuly 29, 2026
Medical and Pharmaceutical Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test The CIZ1B test is meant to complement LDCT in detecting early-stage disease Rowan DunneJuly 23, 2026
Medical and Pharmaceutical AI-powered light scan could speed up targeted lung cancer treatments This technique, fluorescence lifetime imaging microscopy, could save patients and hospitals alot of money Rowan DunneJuly 13, 2026
Medical and Pharmaceutical Liquid chromatography-mass spectrometry proves its worth in lung cancer screening It is highly impactful for blood draws and breath samples Rowan DunneJune 12, 2026
Medical and Pharmaceutical BioMark expands lung cancer screening portfolio with patented urine test It is one of a select few pursuing this variety of diagnostics Rowan DunneJune 10, 2026
Medical and Pharmaceutical AI-powered blood test promises lung cancer detection 5 years in advance British scientists used the biopsy to detect a 14-protein blood signature linked to the disease Rowan DunneJune 4, 2026